Dose Finding Study of GX-H9 in Paeditaric Patients With Growth Hormone Deficiency

NCT03309891 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Growth Hormone Deficiency

Interventions

DRUG: GX-H9
DRUG: Genotropin

Sponsor

Genexine, Inc.